← SynDRA
POZANICLINE
SynDRA canonical compound SYN0004525 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | CHRNA4 | CHRNB2 |
| Mechanism of action | acetylcholine receptor antagonist |
All known targets
- CHRNA4
- CHRNB2
- CHRNA4-CHRNB2
- CHRNA5
- CHRNA6
Mechanisms of action (all sources)
- CHRNB2 PARTIAL AGONIST
- Nicotinic acetylcholine receptor alpha4/beta2/alpha5 partial agonist
- CHRNA4 PARTIAL AGONIST
- CHRNA5 PARTIAL AGONIST
- Neuronal acetylcholine receptor; alpha6/beta2 partial agonist
- CHRNA6 PARTIAL AGONIST
- acetylcholine receptor antagonist
- Modulator
Cross-references
Synonyms
- Pozaniclina
- A-87089.0
- A-870890
- ABT-089
- ABT 089
- A 94224
- Pozanicline (USAN)
- (R)-2-Methyl-3-(2-pyrrolidinylmethoxy)pyridine
- 2-Methyl-3-(2-pyrrolidinylmethoxy)pyridine
- 2-Methyl-3-(2S-pyrrolidinylmethoxy)pyridine
- 2-methyl-3-[[(2R)-pyrrolidin-2-yl]methoxy]pyridine
- 2-methyl-3-[[(2S)-pyrrolidin-2-yl]methoxy]pyridine
- pozaniclina
- CL2002R563
- Pyridine, 2-methyl-3-[(2S)-2-pyrrolidinylmethoxy]-
- Pyridine, 2-methyl-3-((2S)-2-pyrrolidinylmethoxy)-
- pozaniclinum
- RefChem:175661
- ABYT 089
- DTXCID0089640
- 2-methyl-3-(2-pyrrolidinylmethoxy)pyridine, (S)-
- 2-METHYL-3-((2S)-PYRROLIDIN-2-YLMETHOXY)PYRIDINE
- 2-methyl-3-{[(2S)-pyrrolidin-2-yl]methoxy}pyridine
- Pozanicline [USAN]
- Pozanicline [USAN:INN]
- UNII-CL2002R563
- POZANICLINE [INN]
- 2-Methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine
- POZANICLINE [WHO-DD]
- SCHEMBL194037
- orb1706777
- SCHEMBL29378392
- YRVIKLBSVVNSHF-JTQLQIEISA-N
- BDBM50056147
- EBC-46290
- PDSP1_001326
- PDSP2_001310
- AKOS040742435
- DA-50099
Look up POZANICLINE in the interactive SynDRA portal →